Back to Search Start Over

Phosphaturic Mesenchymal Tumors with or without Phosphate Metabolism Derangements

Authors :
Andrea Montanari
Maria Giulia Pirini
Ludovica Lotrecchiano
Lorenzo Di Prinzio
Guido Zavatta
Source :
Current Oncology, Vol 30, Iss 8, Pp 7478-7488 (2023)
Publication Year :
2023
Publisher :
MDPI AG, 2023.

Abstract

Phosphaturic mesenchymal tumors (PMT) are rare neoplasms, which can give rise to a multifaceted syndrome, otherwise called tumor-induced osteomalacia (TIO). Localizing these tumors is crucial to obtain a cure for the phosphate metabolism derangement, which is often the main cause leading the patient to seek medical help, because of invalidating physical and neuromuscular symptoms. A proportion of these tumors is completely silent and may grow unnoticed, unless they become large enough to produce pain or discomfort. FGF-23 can be produced by several benign or malignant PMTs. The phosphate metabolism, radiology and histology of these rare tumors must be collectively assessed by a multidisciplinary team aimed at curing the disease locally and improving patients’ quality of life. This narrative review, authored by multiple specialists of a tertiary care hospital center, will describe endocrine, radiological and histological features of these tumors, as well as present surgical and interventional strategies to manage PMTs.

Details

Language :
English
ISSN :
30080541, 17187729, and 11980052
Volume :
30
Issue :
8
Database :
Directory of Open Access Journals
Journal :
Current Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.f55654a4da74cc097e15ac0d5a5ce7c
Document Type :
article
Full Text :
https://doi.org/10.3390/curroncol30080541